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Elucidating dynamic metabolic 
physiology through network 
integration of quantitative time-
course metabolomics
Aarash Bordbar1,*, James T. Yurkovich2,3,*, Giuseppe Paglia4, Ottar Rolfsson4, 
Ólafur E. Sigurjónsson5,6 & Bernhard O. Palsson2,3,7,8
The increasing availability of metabolomics data necessitates novel methods for deeper data analysis 
and interpretation. We present a flux balance analysis method that allows for the computation of 
dynamic intracellular metabolic changes at the cellular scale through integration of time-course 
absolute quantitative metabolomics. This approach, termed “unsteady-state flux balance analysis” 
(uFBA), is applied to four cellular systems: three dynamic and one steady-state as a negative control. 
uFBA and FBA predictions are contrasted, and uFBA is found to be more accurate in predicting dynamic 
metabolic flux states for red blood cells, platelets, and Saccharomyces cerevisiae. Notably, only uFBA 
predicts that stored red blood cells metabolize TCA intermediates to regenerate important cofactors, 
such as ATP, NADH, and NADPH. These pathway usage predictions were subsequently validated 
through 13C isotopic labeling and metabolic flux analysis in stored red blood cells. Utilizing time-course 
metabolomics data, uFBA provides an accurate method to predict metabolic physiology at the cellular 
scale for dynamic systems.
In recent years, the availability and use of metabolite profiling has substantially increased, allowing for a func-
tional readout of the multitude of influences on cellular biochemistry1. Further, time-course metabolomics has 
allowed the integration of multiple static snapshots to infer biochemical activity, providing more physiological 
insight, such as in cancer metabolism2. Due to the complexities of the associated analytical chemistry, metabo-
lomics has a low signal to noise ratio, and relatively fewer datasets have been generated than for transcriptomics. 
Thus, formal analysis of metabolomics data is in its infancy as compared with other established omics data types.
One advantage of using metabolomics data is that high-quality, mechanistic models of metabolism are avail-
able3. Metabolic reaction networks can be represented mathematically and interrogated using ordinary differ-
ential equations, metabolic flux analysis, or constraint-based modeling. Constraint-based modeling formalizes 
biochemical, genetic, and genomic knowledge of cellular metabolism into a mechanistic model and is suited for 
understanding systems level metabolic physiology without the need for extensive parameterization4. Over the 
past decade, constraint-based modeling methods have developed to better constrain biological systems, in part by 
including new types of omics data, especially transcriptomics5. However, fewer studies have integrated metabolo-
mics data with such networks. To date, dynamic simulations have primarily integrated or modeled extracellular 
metabolite concentrations6,7, with some exceptions mentioned in the Discussion8,9. Without including intracel-
lular concentrations, models can overlook the impact of large intracellular metabolite pools on metabolic flux10. 
Thus, there is a need for methods that can integrate changes in intracellular metabolite data with mechanistic 
models to accurately predict metabolic physiology under dynamic conditions.
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In this study, we present unsteady-state flux balance analysis (uFBA), a constraint-based modeling method 
and workflow that integrates time-course metabolomics data to predict metabolic flux states for dynamic systems. 
uFBA and steady-state FBA (henceforth referred to simply as FBA) models were constructed and compared for 
three dynamic systems: stored human red blood cells (RBCs), stored human platelets, and Saccharomyces cerevisiae 
during anaerobic batch fermentation and carbon starvation. In addition, one classical example of a static system 
was modeled: Escherichia coli during steady-state exponential growth. We find that for the dynamic systems, 
inclusion of intracellular metabolomics with uFBA provides different and more accurate predictions than FBA. 
In particular, uFBA predictions for RBC were experimentally validated with isotopic metabolic flux analysis. For 
the platelet and yeast systems, experimental data from the literature was used to benchmark the modeling results. 
Finally, the static E. coli system served as a negative control, with uFBA and FBA displaying similar predictions.
Results
Unsteady-state Flux Balance Analysis (uFBA). The uFBA workflow integrates time-course absolute 
quantitative metabolomics data with a constraint-based model to predict metabolic flux states. Time-course 
metabolomics data is often non-linear. The first step of the workflow discretizes non-linear metabolite time pro-
files into time intervals of linearized metabolic states for piecewise simulation, resulting in a separate model for 
each metabolic state (Fig. 1). Principal component analysis (PCA) is applied to the time-course metabolomics 
data to identify the time intervals for which a model will be constructed. For example, the data in Fig. 1 is discre-
tized into two time intervals.
For each time interval, a parameterized model is constructed by (1) determining the rate of change of meas-
ured metabolites using linear regression, (2) integrating the calculated rates of change with the constraint-based 
model, (3) treating the model as a closed system, and (4) reconciling data measurement error and incompleteness 
through a metabolite node relaxation algorithm to produce a functional model.
The final two steps are different than traditional FBA. uFBA is a data driven approach and aims to make flux 
predictions solely from time-course metabolomics data. uFBA only allows changes to metabolite levels, including 
extracellular metabolites for exchange, if the metabolite is measured to be significantly increasing or decreasing 
in the extracellular (exo) or intracellular (endo) metabolomics data. In principle, if all metabolites are accurately 
measured over time, the model should simulate. However, due to the experimental infeasibility of data complete-
ness (not all metabolites are measured), additional metabolites will need to accumulate or deplete for proper sim-
ulation. To predict which unmeasured metabolites are changing, we developed a relaxation algorithm that makes 
the model simulation feasible. After all exchange reactions are removed (i.e., a closed system), the metabolite node 
relaxation algorithm determines the minimum number of metabolites that need to deviate from steady-state for 
a feasible model. The algorithm and its benchmarking are detailed in the Methods and Supplementary Material.
Once the uFBA model is constructed, most constraint-based modeling analyses can be used, including the 
maximization or minimization of an objective, flux variability analysis (FVA), and candidate flux sampling. For 
this study, we focused on Markov chain Monte Carlo (MCMC) sampling11 to calculate the probability distribution 
of flux through every metabolic enzyme in the network. This allowed for the calculation of the most likely flux 
state of the system.
Global Differences between uFBA and FBA. To test and validate uFBA, the workflow was applied to 
four systems: (1) human red blood cells (RBCs) stored up to 45 days at 4 °C; (2) human platelets stored up to 
10 days at 22 °C; (3) two strains of Saccharomyces cerevisiae during anaerobic batch fermentation and carbon 
starvation, and (4) Escherichia coli during steady-state exponential growth as a negative control. These cases were 
chosen because they represent diverse systems in terms of physiological dynamics, metabolic network complexity, 
cell density, data coverage, and timescales (Supplementary Table 1 and Supplementary Fig. 1).
Figure 1. Overview of the uFBA workflow. First, extracellular (exo) and intracellular (endo) metabolite time 
profiles are split into discrete time intervals of linearized metabolic states using principal component analysis. 
For each metabolic state, the rate of change of each metabolite is calculated using linear regression, along with 
the 95% confidence interval (b1 and b2). If the metabolite’s rate of change is significant, the model is updated 
by changing the steady-state constraint b = 0 to a range denoted by b1 and b2. uFBA differs from FBA in that 
elements of the b vector are known and can be used as constraints, but FBA in the absence of such information 
assumes that these elements are zero (i.e., at steady-state).
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3Scientific RepoRts | 7:46249 | DOI: 10.1038/srep46249
Comprehensive absolute quantitative metabolomics data was obtained from the literature12–15. All four data-
sets were generated using LC-MS methods, augmented with some extracellular metabolites being measured by 
HPLC or a blood gas analyzer. Using PCA, the metabolite time profiles for stored RBCs were discretized into three 
metabolic states, into two states for stored platelets, and into three states for S. cerevisiae during mixed glucose/
xylose fermentation (Supplementary Fig. 2). The negative control, E. coli steady-state growth, was treated as one 
state. uFBA models were constructed and compared to steady-state FBA models for the corresponding systems 
and states. The steady-state models were constructed by integrating only the exometabolomics data and allowing 
for extracellular exchange for unmeasured metabolites with the environment, currently a standard practice.
We assessed the global difference between calculated flux states of the uFBA and FBA models (Fig. 2 and 
Supplementary Fig. 7). We observed considerable differences between uFBA and FBA predictions in the dynamic 
situations of long-term cell storage or batch fermentation, while fewer differences were observed for E. coli dur-
ing steady-state growth. Further, the detected differences in flux estimates were not due to a uniform increase or 
decrease of flux across the network as evidenced by the significantly lower correlation of uFBA and FBA calcu-
lated fluxes as compared to controls (Fig. 2b). This indicates that the ordering of reactions, from high to low flux, 
had fundamentally changed in RBCs, platelets, and S. cerevisiae.
Reactions with significantly different flux estimates between uFBA and FBA were not uniformly distributed 
across the subsystems of the various models (see Supplementary Fig. 6). Typically, higher metabolomics coverage 
of metabolites in a particular subsystem resulted in larger reported flux differences. Further, the number of sig-
nificantly different reactions within a given subsystem was not constant across metabolic states. This difference is 
due to the nonlinearity of time-course data, where some metabolite concentrations change during one metabolic 
state but are at steady-state during another metabolic state.
Outside of MCMC sampling flux states, we assessed whether the size of the solution space had changed by 
uFBA using flux variability analysis (FVA). We applied FVA to each state of each test case to determine the flux 
range for each metabolic reaction (flux range = maximum flux − minimum flux). The ratio of the feasible flux 
ranges of uFBA and FBA are shown (Supplementary Fig. 8). In the RBC and platelet cases, we found that by 
deviating intracellular metabolites from steady-state, flexibility in the system increased and certain reactions 
had larger flux ranges for uFBA than for FBA. Overall, however, we found that most of the reactions had equal or 
lower flux ranges in the uFBA formulation. The lower flux ranges are most likely due to uFBA constraining extra-
cellular metabolite exchanges to only measured data, and not allowing free exchange out of the system.
After a global comparison of uFBA and FBA, we focused on key differences in reaction flux predictions that 
would have consequences on biological interpretation on metabolic physiology by those investigating the metab-
olomics data.
Red Blood Cells. There were considerable differences in flux predictions made by uFBA and FBA for RBC 
metabolism. To hone in on major discrepancies, we focused on metabolic reactions where uFBA and FBA pre-
dicted opposite directions of flux. We observed flux reversals in the cytosolic remnants of the TCA cycle reactions. 
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Figure 2. Comparison of uFBA and FBA reaction flux states. (a) Percentage of reactions with significantly 
different fluxes between the uFBA and FBA models. (b) The Spearman correlation between uFBA and FBA 
flux states indicates that differences in flux estimates were not due to uniform increases or decreases in fluxes 
but a reordering of reactions from high to low flux. The null hypothesis is that the distribution of Spearman 
correlations is drawn from the same distribution when comparing candidate flux states from uFBA to uFBA or 
FBA to FBA. *p = 0.0; E. coli p = 0.995.
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These enzymes had been previously detected in RBC proteomic datasets16 (Fig. 3a). Over storage, RBCs uptake 
citrate (2.32 μ M/day during State 1) and secrete malate (1.96 μ M/day during State 1) and fumarate (0.300 μ M/ 
day during State 1). FBA predicts that nearly all citrate is converted to malate and fumarate (Fig. 3c). This is a 
reasonable estimation because the flux into and out of the cell is roughly balanced, and the Keq of malate dehydro-
genase (Keq = 2.1 × 105) heavily favors metabolite flow in that direction. However, through intracellular metab-
olite profiling, we discovered that RBCs have a high concentration of intracellular malate (> 1 mM). With this 
additional information, uFBA predicts that the secretion of malate and fumarate are due to the depletion of the 
large intracellular malate pool (26.1 μ M/day, State 1). Further, uFBA predicts the shuttling of the majority of the 
intracellular malate and citrate into lower glycolysis through oxaloacetate, as well as production of glutamate 
from citrate (Fig. 3b). The network in Fig. 3a shows all TCA remnant enzymes previously detected in RBCs in 
proteomic studies16 or through literature curation17.
We experimentally validated the fate of extracellular citrate by replacing the anticoagulant with fully labeled 
13C citrate. Measurements of isotope abundance were determined (see Supplementary Data S1) and analyzed 
using metabolic flux analysis (MFA) tools18. As intracellular metabolite levels are changing throughout and the 
labeling patterns are unstable, traditional “reverse” 13C MFA calculations where fluxes are predicted based on iso-
topic labeling patterns are not applicable. Instead, we completed a “forward” MFA simulation where the isotopic 
Figure 3. Experimental confirmation of differences in predictions between uFBA and FBA models.  
(a) TCA metabolites and pathways in the RBC metabolic model are shown, including changes in metabolite 
levels and metabolites found to be isotopically labeled after addition of fully labeled 13C citrate. Cofactor 
producing reactions are shown, while other cofactors and reaction names are omitted. Concentrations are 
shown as μ mol/L of bag or mmol/L of bag. Time spans 0–45 days for insets. (b) uFBA (blue arrow) predicts 
that the depletion of intracellular malate produces extracellular malate and fumarate, while driving lactate 
production. Extracellular citrate is used to produce glutamate and lactate. Fluxes shown in μ M. (c) FBA (red 
arrow) predicts extracellular citrate is used only to produce malate and fumarate and that MDH proceeds in the 
opposite direction than in uFBA. (d) uFBA and FBA predicted fluxes were integrated with a 13C MFA “forward” 
tracer simulation to simulate how labeled citrate would accumulate across the first two metabolic states. The 
three intracellular metabolites outside of citrate that were observed to be labeled and were absolutely quantified 
are shown. As fully labeled citrate is used, the only labeled versions of lactate and glutamate are shown. The 
unlabeled fraction of the metabolite (not shown) is the remainder. For malate, there is a small percentage of 
m + 3 labeling (see Fig. S11), and the remainder is unlabeled. uFBA predicted more correct labeling patterns 
than FBA. This is quantitatively corroborated by the residual sum of squares (RSS) for each. Abbreviations: oaa: 
oxaloacetate; akg: alpha-ketoglutarate; pep: phosphoenolpyruvate; MDH: malate dehydrogenase; PYK: pyruvate 
kinase; ICDH: isocitrate dehydrogenase. Vertical lines on metabolite time profiles denote the time intervals of 
the three metabolic states.
www.nature.com/scientificreports/
5Scientific RepoRts | 7:46249 | DOI: 10.1038/srep46249
labeling pattern is predicted based on the initial isotopic pattern and the predicted fluxes by uFBA or FBA (see 
Methods). We compared how well the use of uFBA or FBA fluxes were able to match the isotopic labeling pattern 
of intracellular metabolites that were detected to be labeled and for which we had absolute quantitation. uFBA 
produced quantitatively more accurate predictions (lower residual sum of squares (RSS)) than FBA for the iso-
topic labeling pattern (Fig. 3d and Supplementary Fig. 10). The discrepancy between uFBA and FBA is predom-
inantly due to the depletion of intracellular malate into oxaloacetate, which creates a gradient pushing flux from 
malate into oxaloacetate.
RBC citrate metabolism can proceed in two directions. First, alpha-ketoglutarate can be formed through aco-
nitase and isocitrate dehydrogenase (IDH). Alpha-ketoglutarate can then form glutamate, which was found to 
have increasing percentages of isotopic labeling. In this process, NADPH is generated through IDH1, which is 
the only known isozyme proteomically detected in RBCs16. In the second direction, citrate forms oxaloacetate 
through ATP citrate lyase. An acetyl group is cleaved off during this process forming acetyl-CoA. We detected 
an increasing labeling percentage of acetylcarnitine (m + 2), which is most probably created from acetyl-CoA. 
Oxaloacetate can then become aspartate, malate, and lactate, which we found all increasingly labeled. Additional 
labeled metabolites that were not absolutely quantified and thus not included in MFA, such as acetylcarnitine, are 
shown in Supplementary Fig. 11.
Platelets. For the platelet storage data, the major discrepancy between uFBA and FBA models concerned 
the utilization of the electron transport chain (ETC), particularly in State 1. As this dataset did not have infor-
mation on oxygen uptake, the metabolite node relaxation algorithm determined the necessary amount based 
on the rest of the metabolomics data. Based on the measured metabolites, the algorithm was able to accurately 
predict that oxygen was required for both uFBA and FBA models, but the amount of oxygen needed was only 
quantitatively predicted on the right order of magnitude for uFBA (see Supplementary Table 7). uFBA predicted 
that the ETC accounted for 90.2% and 88.8% of ATP generation for States 1 and 2, respectively. However, FBA 
predicted 0.23% and 64.1% in States 1 and 2, respectively, suggesting that platelets use only glycolysis for ATP 
generation (and not the ETC) in State 1. Previous experimental studies19,20 have shown oxygen uptake to be 
higher in State 1 than in State 2 and that approximately 85% of ATP production during storage is due to the ETC. 
The uFBA workflow quantitatively predicted the oxygen uptake rate and ATP production. When the FBA models 
were re-parameterized to not allow free exchange out of the system, the oxygen uptake rate and ETC usage was 
corrected. The discrepancy between the uFBA and FBA model predictions was determined to be caused by the 
standard practice in FBA models to allow free exchange of metabolites out of the system, In particular, the reason 
was free exchange of L-alanine out of the system.
Saccharomyces cerevisiae. The final dynamic case study used metabolomics data for two S. cerevisiae 
strains engineered to assimilate xylose and fermented in a mixed glucose/xylose culture14. One strain consumes 
xylose through an isomerase (strain XI), while the other consumes xylose through a reductase and a dehydro-
genase (strain XR). The PCA identified three metabolic intervals. The first shift differentiated between mixed 
nutrient metabolism (glucose/xylose, State 1) and xylose as the sole carbon source (States 2 and 3). Using a 
constraint-based model for yeast metabolism, we found considerable differences between uFBA and FBA flux 
predictions (Fig. 2). We compared the flux predictions against recently generated 13C MFA studies on XI and 
XR yeast strains21,22. Although the experimental conditions were not identical (see Supplementary Material), the 
uFBA model’s predicted flux state (see Supplementary Tables 9–11) resulted in a lower residual normalized error 
(see Supplementary Table 12) than did FBA when compared with the measured data for the three tested cases: XR 
growth on glucose (State 1) and xylose (State 3); XI growth on glucose (State 1). XI growth on xylose (State 3) was 
excluded for comparison as the growth rate of yeast in the 13C MFA study was considerably different than in the 
study used for generating uFBA and FBA predictions.
Further, the uFBA flux predictions provide a systematic method to propose mechanisms for the observed 
time-course changes in metabolites, rather than use intuition. In particular, the authors postulated that the 
observed drain of 6-phosphogluconate (6PG) in the XI strain after glucose consumption is due to a reduced flux 
through the non-oxidative PPP. uFBA instead predicts 6PG decrease to be due to a significant decrease in oxida-
tive PPP activity in State 2. The FBA model did not make a similar prediction. Further, the large decrease in flux 
through the oxidative PPP predicted by uFBA was confirmed with the 13C MFA studies on yeast XI and XR strains 
noted above. Additional systematically derived hypotheses for observations in the yeast metabolomics data are 
discussed in the Supplementary Material.
Escherichia coli. The E. coli data was used as a negative control because FBA has been traditionally successful 
in analyzing microbial growth processes based on exometabolomic data alone, in part due to E. coli’s balanced 
growth nature. As expected, uFBA flux predictions deviated less from steady-state flux predictions than did the 
other test cases (Fig. 2). The similar results demonstrate that the differences observed in the other case studies are 
not artifacts of the uFBA workflow.
Though flux predictions are not substantially affected, the inclusion of endometabolomics measurements 
does impact gene essentiality predictions in E. coli. Overall results were very similar for the 1,366 genes in the 
model, but uFBA predicted non-essentiality for 11 genes that FBA predicted to be essential in glucose minimal 
media. Like other linear programing based constraint-based methods, uFBA cannot explicitly account for metab-
olites as variables. uFBA incorporates the rate of depleting intracellular metabolites without accounting for the 
metabolite concentration, thus providing an infinite supply of the metabolite, increasing chances of predicting 
non-essentiality. This artifact of depleting pools is similar to potential reasons for conflicts in experimental gene 
essentiality results in minimal media. Experimentally, 17.8% of genes predicted to be essential by uFBA have con-
flicting experimental results across three studies23–25 in glucose minimal media. The 11 differing predictions were 
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enriched in conflicting experimental results (3.06x enrichment, p = 0.0032), suggesting that the measured drains 
in intracellular metabolites may play a role in conflicting experimental results. The genes were related to NAD 
and AMP biosynthesis (Supplementary Table 13), which were rescued by the measured depletion of the cofactor 
pools during growth. The observed discrepancies in gene essentiality calls may be due to differences in plating 
techniques, the time point for assaying growth, or the chosen growth/no growth threshold. Residual intracellular 
metabolite pools from LB media before plating may play a role in causing conflicting results. These results suggest 
that E. coli retains higher than required cofactor levels in anticipation of changing environmental conditions, a 
result consistent with the finding that intracellular concentrations of ATP and NAD pools in E. coli are an order 
of magnitude higher than Km’s of their associated enzymes26.
Discussion
Metabolomics data provides a rich detailing of cellular biochemistry. Metabolomics data is becoming readily 
available, and there is still a need for tools that can integrate such data into mechanistic models to provide a 
deeper understanding of systems level metabolic physiology. Statistical methods can pinpoint changes or associ-
ations but have difficulty elucidating mechanisms. Metabolic modeling techniques can predict which metabolic 
pathways or enzymes caused the observed statistical changes (i.e., whether upstream or downstream enzymes are 
more likely the cause of observed behavior), although more detailed, kinetic modeling and metabolic flux analysis 
are often difficult to construct and parameterize for large cellular networks. Constraint-based models are better 
suited for studying metabolism at cellular scale, but the steady-state assumption hinders studying dynamic states.
In this study, we present unsteady-state flux balance analysis, a constraint-based modeling method, to study 
dynamic cellular states. uFBA provides additional utility to existing constraint-based methods that integrate 
metabolomics data (see Supplementary Material). We identified four test cases and for each, compared uFBA 
flux predictions with steady-state FBA in order to quantify the advantages of integrating intracellular metabolite 
concentrations. For the three dynamic systems, we found considerable differences in flux predictions. The size 
of the metabolic network and data coverage (i.e., what percentage of metabolites are measured) impacts the 
increased utility of uFBA over traditional FBA as evidenced by the significant differences in RBCs and less sig-
nificant differences in S. cerevisiae. For a more traditional use of FBA (steady-state bacterial growth), we found 
less difference, confirming that the uFBA is not overly sensitive. Theoretically, in a system where no intracellular 
metabolites change over time, uFBA and FBA would predict identical flux distributions, indicating that the use of 
uFBA should be considered if metabolomics measurements are available.
The results presented here have two major implications. First, uFBA quantifies the impact of large and previ-
ously unmeasured intracellular metabolite concentration pools on network flux calculations. We experimentally 
validated a notable uFBA prediction for RBCs using isotopic labeling and metabolic flux analysis. The unex-
pected complexity of TCA metabolism in human RBCs is biologically notable. RBCs utilize TCA intermediates 
to produce phosphoenolpyruvate (PEP), most probably through a PEP carboxylase-like mechanism mediated 
by hemoglobin27 which ultimately results to ATP generation by pyruvate kinase. Further, RBCs produce NADH 
and NADPH outside of glyceraldehyde dehydrogenase and the pentose phosphate pathway through the cytosolic 
forms of malate dehydrogenase and isocitrate dehydrogenase, respectively. This finding may be of importance in 
transfusion medicine as some of the FDA approved media additives for RBC cold storage contain large amounts 
of citrate (20 mM), while other additives do not. The added citrate may affect the red blood cell’s ability to combat 
oxidative stress during RBC storage28. This discovery was only possible through absolute quantitative metabolo-
mics and uFBA. The high levels of intracellular malate (> 1 mM) had not been previously observed. Without the 
intracellular data, the uptake and secretion of metabolites by RBCs was still mass balanced so FBA predictions 
would have been inaccurate but still feasible. This example shows the importance of combining comprehensive 
intracellular metabolomics with network calculations. Further, as the labeling percentage of malate is less than 5% 
at day 1 (Fig. 3d), the concentration of malate is not due to RBC storage in citrate anti-coagulant.
Second, the common practice to allow free metabolic exchange of unmeasured metabolites out of the sys-
tem can lead to erroneous predictions. For the platelet data, FBA predictions were inaccurate partly due to free 
exchange of L-alanine out of the system. For the yeast example, differences in FBA and uFBA predictions were 
partly due to the use of exchange reactions. uFBA aims to be fully data driven and only allows exchange of metab-
olites out of the system if they were experimentally measured or if the optimization algorithm requires the metab-
olite to be secreted for model feasibility. With the increasing size of metabolic networks, it requires both intimate 
knowledge of the cellular system and of constraint-based modeling to identify the modeling inaccuracies caused 
from metabolic exchanges. The uFBA approach simplifies metabolomics data integration and accurately deals 
with data inconsistencies through the node relaxation algorithm.
Two other methods for systematically integrating intracellular metabolite concentrations with 
constraint-based models are available. TREM-Flux9 and MetDFBA8 have important methodological differences 
from uFBA. First, TREM-Flux estimates network flux between each two time points, making the approach 
extremely susceptible to data noise and outliers. The uFBA approach avoids this issue by defining time intervals 
that represent metabolic states, effectively lowering the chances that noise and outliers affect flux predictions. 
Second and more importantly, TREM-Flux accounts for data incompleteness by allowing all unmeasured metab-
olites to deviate from steady state up to the maximum change measured in the metabolomics data. Such an 
approach provides too much freedom in the optimization problem, making many fluxes inaccurate. uFBA deals 
with data incompleteness by modifying the fewest number of metabolites using the metabolite node relaxation 
algorithm.
MetDFBA integrates intracellular measurements with the traditional DFBA approach. In order to deal with 
the huge complexity of the necessary ordinary differential equations, MetDFBA lumps and removes the major-
ity of metabolic reactions resulting in smaller, core networks. While focusing on specific cellular processes is 
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common in kinetic modeling, it eliminates the ability to interrogate metabolism at the whole-cell level, which is 
possible with FBA methods. Though uFBA is not as detailed as MetDFBA, it allows for studying metabolism at a 
comprehensive scale.
The integration of metabolomics data using uFBA has limitations. First, the metabolomics data used to con-
strain the model must be absolutely quantified using internal standards. Absolutely quantified metabolomics data 
is often difficult to generate accurately and is more expensive. Second, the increased accuracy of uFBA predictions 
are determined by how large a percentage of metabolites are measured in the network. In particular, it is impor-
tant to have metabolite measurements for cofactors and high flux pathways. Third, like other constraint-based 
methods, uFBA does not explicitly model metabolites as variables and thus total concentrations are not captured. 
Fourth, organelle specificity of metabolite concentrations is often lacking, requiring modelers to make assump-
tions on metabolite location. Finally, metabolomics data is noisier than other omics data types. To calculate sig-
nificant metabolic rates of change, uFBA may require more than three replicates.
uFBA provides a systematic and standardized method to generate hypotheses for the causes of detected 
changes in metabolite levels over time. uFBA flux predictions are based on unlabeled metabolomics but provide 
high quantitative accuracy in flux estimates even during dynamic metabolic conditions. These findings are not 
evident from statistical analysis of the time-course metabolomics alone nor from standard analysis of FBA models. 
We anticipate that the use of uFBA and the associated workflow will aid in deeper analysis of metabolomics data 
while also increasing the predictive power of constraint-based models.
Materials and Methods
All analyses were performed in Matlab (Mathworks, Natick, MA) using the COBRA 2.0 Toolbox11. The uFBA 
method and associated workflow are available as an extension for COBRA 2.0 at (https://opencobra.github.io/
cobratoolbox/).
Data Preparation. Red blood cell (RBC) metabolomics data from normal blood banking conditions using 
SAGM media was taken from ref. 12. Metabolomics data for platelets retrieved by apheresis during storage under 
normal blood banking conditions was taken from ref. 13. Metabolomics data for S. cerevisiae during mixed cul-
ture anaerobic fermentation was taken from ref. 14. Metabolomics data for E. coli during exponential growth was 
taken from ref. 15. Missing values were imputed using a k-nearest neighbor algorithm that takes the weighted 
average of the five nearest neighbors; this approach has been previously shown to be accurate for metabolomics 
data29. The intracellular and extracellular concentrations were adjusted so that concentrations were in mmol/L of 
total bag volume for RBCs and platelets, and mmol/gDW for S. cerevisiae and E. coli. For RBC and platelet data-
sets, glucose and lactate were measured using a blood gas analyzer. For RBC data, ATP and 2,3 DPG were meas-
ured using enzymatic assays. In Bergdahl et al. and McCloskey et al., changes in key extracellular metabolites in S. 
cerevisiae (glucose, xylose, xylitol, ethanol, and glycerol) and E. coli (glucose, acetate, succinate, and formate) were 
also measured using HPLC. The low-throughput and HPLC measurements were prioritized over mass spectrom-
etry measurements for use in the model. Some metabolite pools were not resolved in the original data and were 
manually split into individual concentrations based on known physiological ratios (3-Phospho-D-glycerate/D- 
Glycerate 2-phosphate, pentose sugars, leucine/isoleucine). Due to the rigorous quality control standards within 
blood banks for those two publications, there was negligible RBC and platelet cell death during storage. Thus, cell 
death was not included during modeling.
Principal component analysis and linear regression. Principal component analysis (PCA) was per-
formed on each metabolomics data set in order to objectively determine the time intervals of the discrete, line-
arized metabolic states. PCA was performed on the standardized Z-scores. Once the time intervals for each state 
were defined, linear regression was performed in order to estimate the rate of change for each metabolite during 
that particular state. The 95% confidence interval for each metabolite’s rate of change was calculated for integra-
tion with the model. If the 95% confidence interval for a particular metabolite’s rate of change crossed zero, the 
metabolite was deemed to be at steady-state as there is not enough statistical evidence for the metabolite to be 
changing. Rates for RBC and platelet were in mmol/L/h, while S. cerevisiae and E. coli rates were in mmol/gDW/h.
Constraint-based model integration. The endometabolomics data acquired from the literature was inte-
grated with constraint-based models. The RBC data was integrated with a modified version of the erythrocyte 
model iAB-RBC-28317, which was previously used for building personalized kinetic models30. The platelet data 
was integrated with the platelet metabolic model iAT-PLT-63631. The S. cerevisiae data was integrated with the S. 
cerevisiae metabolic model iMM90432. The E. coli data was integrated with the E. coli metabolic model iJO136623. 
The measured growth rate was included as a constraint for S. cerevisiae and E. coli simulations. Platelet and S. cer-
evisiae metabolic models contain multiple compartments. If metabolites were known to be predominantly from 
a specific compartment, the metabolomics data was assigned as such. Specifically, tricarboxylic acid cycle metab-
olites were set to the mitochondria. If no information was available, metabolite concentrations were assumed to 
be in the cytosol.
Unsteady-state flux balance analysis (uFBA). The significant rates of change for measured metabolites 
for each state (as determined by linear regression) are input to the uFBA method. All four test cases are treated 
as closed systems, and all exchange reactions were removed from the model. Subsequent steps (see next section) 
determine other metabolites that can enter or leave the system. The measured metabolomics data is integrated 
with the model by:
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⋅ ≥S v b (1)1
⋅ ≤S v b (2)2
where S is the stoichiometric matrix, v is the calculated flux vector, and [b1, b2] represent the 95% confidence 
interval for each significantly changing metabolite. All unmeasured metabolites are assumed to be at steady-state: 
b1 = 0 and b2 = 0.
Ideally, all model metabolites would be accurately measured. If so, the model would properly simulate, as all 
metabolic changes would be accounted for. However, due to experimental limitations, most metabolites cannot 
be measured, and often those that can be measured are done so unreliably. Optimally, one would measure metab-
olites that have the highest rate of change relative to the flux going through the associated pathways. However, 
knowing which metabolites these are may not be possible as such metabolites may change from condition to 
condition or the system being studied may not be well known. Thus, from any metabolomics dataset, there exists 
unmeasured intracellular or extracellular metabolites that are not at steady-state that are required to change in 
order to allow the model to simulate.
To deal with this data incompleteness and data quality issue, we developed an algorithm to reconcile the 
metabolomics data and the network structure. In brief, the algorithm tries to parsimoniously allow unmeasured 
metabolites to deviate from steady-state in order to build a computable mode. The approach is detailed in the 
next section.
Further, a standard practice in FBA is to allow all extracellular metabolites to have free exchange out of the 
system. As uFBA is a metabolomics driven approach, uFBA only allows exchange of extracellular metabolites out 
of the system if (1) it is measured to be increasing in the exometabolomics data, or (2) it is required by the metab-
olite node relaxation algorithm for feasibility.
The remainder of the uFBA modeling formalism follows FBA principles. In particular, a biomass objective 
function is used in growing cells such as S. cerevisiae and E. coli to account for the generation of proteins, RNA, 
DNA, and lipids. Further, metabolite reserves are modeled using sinks. This is used in particular for glycogen 
stores for S. cerevisiae during carbon starvation.
From a mathematical standpoint, the uFBA approach changes the degrees of freedom (DOF) of the system. 
First, for each “unsteady” metabolite incorporated, the system gains a DOF. Next, all exchange reactions are 
removed, reducing the DOF by the number of reactions removed. At this point, the metabolic model is most 
likely infeasible as the system is now over-determined. Previous approaches (i.e. TREM-Flux) deal with this issue 
by allowing all unmeasured metabolites to deviate from steady-state, increasing the DOF by one for each unmeas-
ured metabolite. The uFBA approach applies a metabolite node relaxation algorithm to parsimoniously deviate 
unmeasured metabolites from steady-state to minimize the increase of DOF. The system’s increase in DOF is 
equivalent to the number of metabolites deviated by the algorithm.
Unmeasured metabolite relaxation from steady-state. Because not every metabolite in the network 
was measured, we developed an automated method for parsimoniously deviating unmeasured metabolites from 
steady-state to build a computable model. We term this estimation “metabolite node relaxation”.
For each metabolite that was not measured, two sink reactions are added that allow each of these metabolites 
to both accumulate (“up” sink reaction) and deplete (“down” sink reaction). Then, an optimization problem deter-
mines the minimal number of sinks to retain while still having a computable model. This parsimonious method 
was chosen under the assumption that cellular systems typically aim to maintain homeostatic levels, which has 
been previously shown33.
To exhaust potential methods, we implemented five different optimization approaches for relaxing the 
unmeasured metabolite nodes in the system (Equations 3–7) that all assume parsimony but in slightly different 
ways. The first technique is an MILP optimization that minimizes the number of unmeasured metabolites relaxed 
from steady-state (Equation 3):
∑ ∆ ≠“Case 1” min 1 (3)i
m
x 0i
where m is the number of unmeasured metabolites in the system and ∆x is the deviation from steady-state of the 
unmeasured metabolites, which is defined as the flux through the sink reaction. Essentially, Case 1 minimizes the 
increase of the DOF. The second technique is an LP optimization that minimizes the sum of the magnitude of the 
rate of change of unmeasured metabolites (Equation 4):
∑ ∆ .x“Case 2” min
(4)i
m
i
The third technique is also an LP optimization that minimizes both the sum of the magnitude of the rate of 
change of the unmeasured metabolites as well as the reactions fluxes in the network (Equation 5):
∑ ∑|∆ | +x v“Case 3” min
(5)i
m
i
j
n
j
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where n is the number of intracellular reactions in the system and v is the reaction flux. The fourth technique 
is a QP optimization that minimizes the sum of the square of the rate of change of the unmeasured metabolites 
(Equation 6):
∑∆ .x“Case 4” min
(6)i
m
i
2
The fifth technique is also a QP optimization that minimizes the sum of the square of the rate of change of the 
unmeasured metabolites and the square of the intracellular reaction fluxes (Equation 7):
∑ ∑∆ + .x v“Case 5” min
(7)i
m
i
j
n
j
2 2
As alternative optima may exist for these optimization problems, especially for Case 1, the given optimization 
problem is run multiple times for a user-specified number of iterations, not allowing for previous solutions using 
an integer cut method. For the larger models (platelet, S. cerevisiae, and E. coli), the termination criterion for opti-
mization for each iteration was set to a relative gap tolerance of 1e-6 or a time limit of 45 seconds. These criteria 
were chosen based on convergence properties of the solutions as the two parameters were varied.
The multiple solutions are tallied, and a final optimization is run, preferentially weighting unmeasured metab-
olites that appeared more frequently in the multiple solutions. The sinks associated with the relaxed nodes are 
retained, while the remaining sinks are removed from the model. 100 iterations were used in this study. A com-
parison of the accuracy of the optimization approaches in determining necessary relaxations is discussed in the 
next section. Further, we provide the user with the option to preferentially weight unmeasured extracellular 
metabolite nodes to be relaxed first, as such an approach is similar to the common practice of modifying extra-
cellular exchanges in FBA models.
Once the final set of unmeasured metabolites to be relaxed from steady-state has been determined, the mag-
nitude of relaxation is addressed. The flux through the retained sink reactions is minimized while allowing the 
model to simulate. We tested whether increasing this minimum amount affected flux simulations (scaling the 
minimum bound by 1x, 1.5x, 5x, 10x, or 100x). Sensitivity analysis of this parameter by resampling the reaction 
fluxes showed that the 1x scaling was too tightly constrained, yielding different results than the higher mul-
tiples. However, the higher multiples were very similar to each other. A scaling of 1.5x was used for all analy-
ses in this study as it does not over constrain the network. A full sensitivity analysis for how varying both the 
cases and the scaling values affects uFBA flux predictions and the comparison of uFBA and FBA is shown in the 
Supplementary Material.
Accuracy of unmeasured metabolite relaxation from steady-state. We tested whether the various 
optimization approaches for parsimoniously relaxing unmeasured metabolites from steady-state was an accu-
rate method for the data incompleteness issue. All five techniques were used to build uFBA models for the RBC 
metabolomics data. The relaxed nodes for each of the five approaches (see Supplementary Data S2) were com-
pared to a qualitative dataset (Personal Communication with Angelo D’Alessandro) for the same condition that 
measured many more metabolites than our absolute concentration dataset. The larger dataset had qualitative 
information on the changes (or lack thereof) for 31 metabolites that were unmeasured in the absolute concen-
tration dataset (see Supplementary Data S3). Based on the time points measured in the qualitative dataset, only 
states 1 and 3 in the RBC could be compared. Metabolites that increased 2x or decreased 0.5x were deemed to be 
changing in the qualitative dataset.
The criterion for selecting the best optimization technique was minimizing the number of cases where a 
metabolite was incorrectly relaxed from steady-state. This criterion was chosen as it is more detrimental to over 
relax than to under relax, because it allows the model to have many new feasible flux states that may be erroneous. 
We found the MILP formulation (Case 1) to be the best method for this criterion. Further, the MILP formulation 
was also found to have the overall best accuracy (see Supplementary Table 3). For all analyses in the main text, 
the MILP formulation is used.
Construction of FBA models. The FBA models constructed for control comparison against the uFBA mod-
els followed the same workflow as the uFBA model, except that only the exometabolomics data was integrated. 
Further, in order to satisfy the intracellular steady-state requirements for FBA, models are typically allowed to 
have free extracellular metabolite exchange out of the system. This practice was used for the FBA models in this 
study. Still, the optimization algorithms for node relaxation were required and were used in the same manner as 
that for uFBA. A list of relaxed nodes for the FBA models is provided (see Supplementary Data S2).
Markov chain Monte Carlo (MCMC) sampling and gene essentiality. The FBA and uFBA models 
were sampled using Markov chain Monte Carlo (MCMC) sampling methods11. We sampled 5,000 points for the 
RBC model and 10,000 points for the platelet, S. cerevisiae, and E. coli models; all models were sampled until the 
mixed fraction was below a threshold of 0.54. The sampling distributions for each reaction were deemed signif-
icantly different between modeling formulations (uFBA vs FBA) if the two distributions overlapped by less than 
5%. The correlations which are represented as histograms in Fig. 2b of the main text were calculated using the 
Spearman correlation of two sampled flux vectors. The process was repeated 5,000 times for the RBC model and 
10,000 times for the platelet, S. cerevisiae, and E. coli models to account for all generated sample points. For all 
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determining significant differences and Spearman correlations (including controls), only reactions that were in 
both models and were not involved in type 3 loops were compared.
Gene essentiality predictions were completed with COBRA 2.011. The threshold for growth was set to 1% of 
the growth rate experimentally determined in the publication of the metabolomics dataset15. All bounds and con-
straints that conflict with the zero vector being a feasible solution were modified to allow for proper simulation. 
Metabolic exchange out of the system for the uFBA model was also allowed. Computational predictions were 
compared to four data sets of glucose minimal media in three publications23–25.
13C labeling citrate experiment. A healthy donor was recruited and, after obtaining informed consent, 
red cells were obtained using ISO 9001:2008 certified red cell isolation protocols at the Landspitali-University 
Hospital Iceland Blood Bank. The study and all associated methods were approved by The National Bioethics 
Committee of Iceland and the Icelandic Data Protection Authority. The methods were carried out in accordance 
with the guidelines and regulations outlined by those committees.
Isolated red cells were added to 65 ml of modified Citrate Phosphate Dextrose (CPD) solution containing 
105 mM uniformly labeled 13C citrate (~78% m + 6, 1.5% m + 5, 20.5% m + 0) in place of unlabeled citrate in 
regular CPD SAGM media. Sodium hydroxide was use to match ionic strength imposed by trisodium citrate in 
regular CPD SAGM (Fenwal, Lake Zurich, IL, USA). As a negative control, red cells were stored in unmodified 
CPD SAGM. RBC units were stored at 4 °C. 5 mL samples were removed at ten time points and aliquoted accord-
ingly for subsequent quality control assessment and metabolomics analysis. The experiment was run for 31 days, 
as the shift in metabolic dynamics from State 2 to State 3 occurs much earlier (day 17).
Red cell blood banking quality control assessment was performed immediately by ABL90 FLEX blood gas 
analyzer (Radiometer, Copenhagen, Denmark) determining pH, pO2, pCO2, total hemoglobin, [K+ ], [Na+ ], 
[Ca2+ ], [Cl− ], [Glucose], and [Lactate]. A XN-1000 hematology analyzer (Sysmex, Norderstedt, Germany) was 
used to record RBC count, white blood cell count, platelet count, hemoglobin, % hematocrit, total mean cell 
hemoglobin, mean cell hemoglobin concentration, and red cell distribution width. Labeled samples were found 
to have similar QC properties as control units.
Metabolomic analysis was performed using a previously reported method13,34 based on ultra high perfor-
mance liquid chromatography (UHPLC) (Acquity, Waters, Manchester, UK) coupled with a quadrupole-time of 
flight mass spectrometer (Synapt G2, Waters). Chromatographic separation was achieved by hydrophilic interac-
tion liquid chromatography (HILIC) using an Acquity amide column, 1.7 μ m (2.1 × 150 mm) (Waters).
500 μ L of RBC sample were used for metabolomics analysis and supernatant and cells were separated by cen-
trifugation (1600 g, 4 °C, 15 min). Immediately after centrifugation, cell-free supernatant was removed from cen-
trifuged tubes and collected in separates tubes and processed as previously described13,34.
Data integration of targeted compounds was achieved by using TargetLynx (Waters). Raw data was then cor-
rected for natural abundance of 13C isotopes using IsoCor (MetaSys, Toulouse, France)35 that afforded the % 
isotopes that exceed natural abundance and the corrected isotopic distribution.
Metabolic Flux Analysis. Metabolic flux analysis (MFA) was completed using the INCA software suite18 in 
order to compare the measured isotopic labeling patterns to the flux predictions of the uFBA and FBA models. An 
isotopic model was constructed for the MFA simulations in which all reactions were split into irreversible reac-
tions and metabolic reactions not directly related to citrate metabolism or production of the labeled metabolites 
were omitted (see Supplementary Data S4). For uFBA associated MFA simulations, accumulation or depletion of 
metabolites was modeled using sinks. If a labeled intracellular metabolite was decreasing, the associated sink was 
labeled at the percentage of the initial labeling pattern for that particular state.
The INCA software suite allows for two basic types of simulations: a “forward” simulation in which the labe-
ling pattern is predicted for a given flux state, and a “reverse” simulation in which the flux state of the network is 
calculated based on fitting the experimentally measured labeling pattern. The traditional “reverse” MFA simula-
tion cannot be used when both metabolite levels are changing and the labeling pattern is unsteady. Instead, the 
“forward” simulation was used, which takes as input: (1) measured intracellular metabolite concentrations, (2) 
the labeling pattern of the metabolites, and (3) the flux state of the network. The mean flux state of the network as 
calculated by MCMC sampling for each of the metabolic states for each of the uFBA/FBA models was used as the 
initial flux state labeling pattern on Day 1.
The “forward” MFA simulations were completed for the first two states, where the labeling pattern approaches 
steady-state. First, the initial labeling pattern (Day 1) and the estimated uFBA fluxes were inputted and the labe-
ling pattern was simulated for the duration of State 1. Next, the final predicted labeling pattern and the uFBA 
fluxes for State 2 were simulated for the duration of State 2. The labeling pattern reached steady-state by State 3 
and is not included as there were little differences between uFBA and FBA. The same workflow was also applied 
to the FBA fluxes for comparison.
To assess goodness of fit between the measured data and the simulated data, the residual sum of squares (RSS) 
was calculated for each of the four metabolites for which we had absolute concentrations and labeling data (lac-
tate, glutamate, malate, and citrate). The RSS was calculated by
∑ −
=
y f x( ( ))
(8)i
n
i i
1
2
where y is the experimental value, f(x) is the tracer simulation predicted value and the range of i contains all 
measured time points and each replicate is treated as a separate value. We evaluated the relative difference in RSS 
between the uFBA and FBA simulations to demonstrate the difference in accuracy of predictions. All RSS calcu-
lations were done with log10 transformed abundances.
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Comparison to experimental flux states. Candidate flux states for the uFBA and FBA models were 
determined using MCMC sampling. The mean sampling vector was compared to measured flux values for the XR 
strain growth on glucose and xylose21 and for the XI strain growth on glucose22. Though the experimental con-
ditions were not identical, comparisons were made when the yeast growth rate were similar across the respective 
experimental conditions. Fluxes from metabolic reactions involved in type III pathways that are known to result 
in erroneous flux predictions were omitted for the comparison to measured data. In order to evaluate the error of 
the predicted flux states, we calculated the normalized Euclidean distance given by:
=
−error v v
v (9)
meas pred
meas
where vmeas is the flux vector from MFA measurements and vpred is the flux vector from the uFBA and FBA models.
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